PE/VC  Gurnet Point Capital

http://www.gurnetpointcapital.com





     Office Locations:

55 Cambridge Parkway, Suite 401
Cambridge, MA 02142
Phone: 617-588-4900

 

Stages:

  • Early
  • Expansion
  • Growth
  • Middle Market
  • Seed


 

Industries:

  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    Gurnet Point Capital (GPC) is a healthcare fund founded by Ernesto Bertarelli and led by Christopher A. Viehbacher. With an initial allocation of $2 billion, GPC is investing long-term capital and supporting entrepreneurs in building a new generation of companies. Based in Cambridge, MA, its remit is global, encompassing life sciences and medical technologies. The fund invests across all stages of product development through to commercialization and does so with an approach that is a hybrid of venture and private equity investing strategies. The firm will invest in venture-stage companies with promising scientific innovations and growth- and buyout-ready opportunities with revenue and potential. Through Gurnet's venture investments, the firm will invest $500K to upwards of $20M in seed and traditional venture rounds. Through growth buyouts, Gurnet will make investments ranging from double-digit millions to $1 billion or more.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Christopher A. Viehbacher Managing Partner
    Ernesto Bertarelli Founder
    George Montgomery Partner
    Todd Holmes Director

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      04/02/2018


      Macrolide Pharmaceuticals


      MA


      $20,000,000


      


     

    Portfolio companies include:

     

    Recent News: